Products

qXR-Detect
Qure.ai Technologies
Clinical Decision Support & Reference
Qure.ai's qXR-Detect is an AI software platform for automated abnormality detection on chest radiographs, designed to support early identification, highlighting, and categorizing of key positive findings.
qXR-PTX-PE
Qure.ai Technologies
Radiology & Imaging AI
Qure.ai's qXR-PTX-PE is an FDA-cleared AI solution for rapid triage and notification of pneumothorax and pleural effusion on adult chest X-rays, enhancing workflow prioritization in critical care settings.
qXR-BT
Qure.ai Technologies
Radiology & Imaging AI
Qure.ai's qXR-BT is an FDA-cleared AI algorithm that automates the assessment of breathing tube placement on adult chest X-rays, providing rapid and accurate positional analysis to aid clinicians in critical care settings.

See all 9 products →

About Qure.ai Technologies

Qure.ai Technologies is a leading healthcare AI company dedicated to making healthcare more accessible and affordable globally through deep learning and artificial intelligence. For physicians, Qure.ai offers advanced AI-powered solutions that enhance the accuracy and efficiency of medical image interpretation, including X-rays and CT scans. Their technology is designed to assist in the early detection, diagnosis, and management of a wide range of critical conditions, such as Tuberculosis (TB), lung cancer, stroke, traumatic brain injuries, and heart failure.

The company’s solutions, which include FDA-cleared and CE-marked tools like qXR for chest X-rays and qER for brain CT scans, are deployed across thousands of sites in over 100 countries. These tools help clinicians in emergency rooms and other settings to triage cases more effectively, identify critical scenarios within seconds, and reduce diagnostic errors, ultimately leading to faster interventions and improved patient outcomes. By automating and streamlining aspects of medical imaging diagnostics, Qure.ai empowers healthcare professionals to dedicate more time to direct patient care and complex cases.

Beyond direct diagnostic support, Qure.ai also collaborates with pharmaceutical and medical device industries, as well as public health authorities, to advance AI integration in medical diagnostics and support global health initiatives. Their mission emphasizes bridging diagnostic gaps, particularly in underserved communities, by providing robust AI systems that support professionals and improve the quality of patient life worldwide.

Focus Areas

AI-driven healthcare solutions automated interpretation of radiology exams early detection of tuberculosis lung cancer stroke neurocritical conditions traumatic brain injuries pulmonary nodules heart failure

Business Intelligence

Key InvestorsLightspeed, 360 ONE Asset, Merck Global Health Innovation Fund, Kae Capital, Novo Holdings, HealthQuad, TeamFund, Mass Mutual Ventures, Peak XV Partners, SBRI Healthcare, Fractal Analytics
PartnershipsAstraZeneca, Medtronic, Johnson & Johnson MedTech, Microsoft, Horizon Health Network (Canada), PATH NGO, India Health Fund, NITI Aayog, Piramal Foundation's Piramal Swasthya initiative, NHS, Strategic Radiology, Project Data Sphere
TechnologyDeep learning, AI-powered medical imaging, Large Language Models (LLMs), Agentic AI, cloud-native
FDA Clearances26 cleared products (estimated)

What Physicians Need to Know

Specializations
Qure.ai specializes in AI-driven automated interpretation of radiology exams, including chest X-rays (qXR), head CTs (qER), chest CTs (qCT), and musculoskeletal (MSK) X-rays (qMSK). They focus on early detection and management of critical conditions such as tuberculosis (TB), lung cancer (pulmonary nodules), stroke, neurocritical conditions, traumatic brain injuries (TBI), and heart failure. Their solutions also extend to pediatric TB screening, COVID-19 detection, and automated tumor-burden quantification for oncology trials and monitoring.
Key Differentiators
Qure.ai distinguishes itself through its extensive portfolio of FDA-cleared and CE-marked AI tools, demonstrating a strong commitment to regulatory compliance and clinical validation. Their algorithms are trained on a vast dataset of over 1 billion data points and images, ensuring high accuracy and reliability. They have a proven track record, deployed across over 4,500 sites in more than 100 countries, impacting over 20 million lives. Their solutions significantly reduce turnaround times by up to 40% with a normal-abnormal triage system, and offer 24/7 availability, crucial for remote and underserved areas. Qure.ai emphasizes healthcare equity, making quality diagnostics accessible and affordable globally.
Technology Stack
At its core, Qure.ai leverages deep learning and artificial intelligence, incorporating machine learning and natural language processing (NLP) techniques. For training their algorithms, they utilize high-performance NVIDIA GPUs (H100s and A100s). For offline and edge computing deployments, they use NVIDIA Jetson, allowing for local processing without constant cloud connectivity. Their software stack includes Docker for operating system-level virtualization, Anaconda for Python environments, Django for building RESTful APIs, PyTorch as their deep learning framework, Nginx for web serving and load balancing, uWSGI for handling multiple requests, and Celery as a distributed task queue. They also utilize AWS services like Amazon ECR, CloudFront, and Relational Database Service for scalable and secure cloud deployments.
Physician Tip

For physicians, Qure.ai's solutions offer significant advantages by enhancing diagnostic accuracy and speed, allowing AI algorithms to analyze images in seconds and highlight subtle abnormalities that might otherwise be missed. This leads to faster diagnoses and more timely interventions, ultimately improving patient outcomes and survival rates, particularly in conditions like lung cancer and stroke. The AI acts as a 'radiology assistant,' automating repetitive tasks, providing pre-filled reports, and prioritizing critical cases, which significantly reduces workload and potential burnout, freeing up physicians to focus on complex cases and direct patient care. Furthermore, the technology visualizes what the algorithm 'sees,' fostering trust and understanding in the AI's diagnostic suggestions. Qure.ai's tools also facilitate care coordination through platforms like qTrack, aiding in patient follow-up and communication, and are designed for deployment in diverse settings, from elite trauma centers to mobile units, ensuring access to specialist-level diagnostic support even in resource-constrained areas.

Qure.ai's solutions are designed for seamless integration into existing healthcare IT infrastructure, supporting PACS/RIS, EHR, and teleradiology systems. They offer flexible deployment options, including cloud, hybrid, or on-premise installations, to meet specific hospital IT and compliance requirements, such as GDPR and HIPAA.

Products by Qure.ai Technologies

9 products in the directory

qXR-Detect
Qure.ai Technologies
Clinical Decision Support & Reference
Qure.ai's qXR-Detect is an AI software platform for automated abnormality detection on chest radiographs, designed to support early identification, highlighting, and categorizing of key positive findings.
qXR-PTX-PE
Qure.ai Technologies
Radiology & Imaging AI
Qure.ai's qXR-PTX-PE is an FDA-cleared AI solution for rapid triage and notification of pneumothorax and pleural effusion on adult chest X-rays, enhancing workflow prioritization in critical care settings.
qXR-BT
Qure.ai Technologies
Radiology & Imaging AI
Qure.ai's qXR-BT is an FDA-cleared AI algorithm that automates the assessment of breathing tube placement on adult chest X-rays, providing rapid and accurate positional analysis to aid clinicians in critical care settings.
qER
Qure.ai Technologies
Neurology AI
qER by Qure.ai is an FDA-cleared AI-powered solution for the rapid detection and triage of stroke and traumatic brain injury (TBI) on head CT scans, providing real-time alerts and comprehensive findings to accelerate emergency care decisions.
qER-Quant
Qure.ai Technologies
Neurology AI
Qure.ai's qER-Quant is an AI-powered software for automated analysis and quantification of non-contrast head CT images, aiding in the assessment and monitoring of neurological conditions like TBI, stroke, and hydrocephalus.
qXR-LN
Qure.ai Technologies
Oncology AI
Qure.ai's FDA-cleared qXR-LN is an AI-powered chest X-ray solution designed for enhanced lung nodule detection, aiding radiologists, pulmonologists, and ER physicians in the early identification of lung cancers.
qCT LN Quant
Qure.ai Technologies
Oncology AI
Qure.ai's qCT LN Quant is an FDA-cleared AI solution for advanced quantitative characterization and tracking of solid lung nodules on chest CT scans, supporting early detection and management of lung cancer.
qXR-CTR
Qure.ai Technologies
Cardiology AI
qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
qER-CTA
Qure.ai Technologies
Neurology AI
Qure.ai's qER-CTA is an FDA-cleared AI solution for rapid detection and triage of Large Vessel Occlusions (LVOs) on head CTA scans, designed to accelerate stroke diagnosis and treatment in emergency settings.

What the Web Says

Qure.ai Technologies generally receives positive to mixed reviews, particularly for its AI-powered medical imaging solutions which are praised for accuracy and efficiency. As an employer, reviews are more mixed, with some employees appreciating the work culture and innovation, while others point out challenges related to management and work-life balance.

Overall: Mixed

Strengths

  • High accuracy and efficiency of AI imaging solutions (Qure.ai)
  • Innovative technology in healthcare AI
  • Positive impact on patient care and diagnostics
  • Strong technical team and challenging work (employer)
  • Good learning opportunities and exposure to cutting-edge AI (employer)
  • User-friendly interface for medical professionals (product)

Limitations

  • Challenges with work-life balance (employer)
  • Management and communication issues reported by some employees (employer)
  • Potential for long working hours (employer)
  • Integration complexities with existing hospital systems (product)
  • Pricing can be a concern for smaller institutions (product)
  • Limited specific product reviews available on some platforms

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News/Review Sites, Reddit

Last updated: 2026-07-18

Videos

News, demos, and interviews about Qure.ai Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Qure.ai Technologies →

View all on YouTube

Press & Coverage

Qure.ai
Qure.ai Gets $65M Series D Funding to Expand Healthcare AI
Qure.ai, a global healthcare AI innovator, completed a $65 million Series D funding round led by Lightspeed and 360 One Asset, with participation from Merck Global Health Innovation Fund and Kae Capital. The funding will accelerate expansion into the US market and other geographies, increase investment in foundational AI models, and enable complementary med-tech company acquisitions.
2024-09
Qure.ai
Qure.ai announces strategic investment by Merck Global Health Innovation Fund
Merck Global Health Innovation Fund made a strategic investment in Qure.ai as part of its Series D round, aiming to invest in foundation models for AI in imaging and expand Qure.ai's AI-powered imaging solutions into the US market.
2024-06
Qure.ai
Qure.ai and Microsoft Expand Access AI to Lung Cancer Care
Qure.ai partnered with Microsoft to integrate its lung cancer detection, measurement, and management AI solutions onto the Precision Imaging Network, aiming to streamline deployment to hospitals and health systems across the USA.
2025-11
Qure.ai
Qure.ai Secures Six New FDA Clearances for qXR-Detect
Qure.ai received FDA 510(k) Class II clearance for qXR-Detect, its latest computer-assisted detection (CADe) radiography solution, which powers early identification and categorization of key positive findings on plain film chest X-rays.
2026-02
Qure.ai
Qure.ai Secures Gates Foundation Grant for AI Ultrasound
Qure.ai received a multimillion-dollar grant from the Gates Foundation to develop AI-powered point-of-care ultrasound algorithms for the early detection of TB and pneumonia, and to build a large open-source multi-modal database.
2026-01
Qure.ai
Qure.ai Earns 19th FDA Clearance for Neurocritical AI in U.S
Qure.ai announced its 19th FDA clearance for qER-CTA, a neurocritical algorithm designed to assist clinicians by analyzing CT angiography (CTA) scans for suspected large vessel occlusions (LVOs) in the brain.
2025-10
Cureus
Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment
This article reviews Qure.ai's innovative AI solutions for medical diagnosis and treatment, highlighting the efficacy of its chest X-ray interpretation tool, 'qXR,' in detecting conditions like pulmonary nodules and heart failure.
2024-06
BMJ Open
Radiograph accelerated detection and identification of cancer in the lung (RADICAL): a mixed methods study to assess the clinical effectiveness and acceptability of Qure.ai artificial intelligence software to prioritise chest X-ray (CXR) interpretation
The RADICAL study will evaluate Qure.ai's 'qXR' software in reducing reporting time for suspicious X-rays in NHS Greater Glasgow & Clyde, aiming to improve early lung cancer diagnosis and treatment outcomes.
2024-09

Frequently Asked Questions

Qure.ai provides AI-driven solutions primarily for automated interpretation of X-rays and CT scans, focusing on various conditions. Their flagship products include qXR for chest X-ray interpretation, detecting abnormalities like tuberculosis, lung cancer, pulmonary nodules, and heart failure indicators, and qER for head CT scans, assisting in the diagnosis of traumatic brain injuries (TBI), stroke, and other neurocritical conditions. They also offer solutions for MSK X-Ray reporting and lung nodule management.
Qure.ai ensures accuracy and clinical validity through rigorous development processes, including deep learning algorithms trained on vast datasets, and extensive validation studies. Their solutions have demonstrated high diagnostic accuracy, sensitivity, and specificity in clinical trials, with products like qXR achieving high negative predictive values and strong overall performance. The company also holds numerous regulatory clearances, underscoring the clinical validation of its tools.
Qure.ai has an extensive portfolio of regulatory approvals, including 26 FDA-cleared indications across nine X-ray and CT products, and over 65 CE-certified indications, along with other national validations. The company ensures data privacy and compliance by adhering to standards such as ISO 13485:2016, IEC 62304, HIPAA, and EU-GDPR, implementing measures like data de-identification for cloud processing and offering on-premise deployment options.
Qure.ai's product suite includes qXR for chest X-rays (detecting TB, lung cancer, heart failure, pulmonary nodules) and qER for head CTs (for stroke and TBI), alongside solutions for lung nodule management and MSK X-ray reporting. These AI tools are designed to integrate seamlessly into existing radiology and clinical workflows, providing rapid analysis and decision support to radiologists, pulmonologists, and emergency physicians, thereby enhancing efficiency and patient care.
Qure.ai offers comprehensive support and training to ensure successful implementation and utilization of its AI solutions. This includes dedicated client success partners, 24/7 assistance, personalized onboarding, and customized training programs, such as in-person sessions, webinars, and workshops. They also provide ASRT-approved 'Super User' training in the USA to equip healthcare professionals with the necessary skills for effective AI application.
Qure.ai's revenue model is primarily SaaS-first, with annual and multi-year subscriptions for platform access, accounting for about 70% of recurring revenue. They also offer a flexible pay-per-scan transaction fee, particularly for emerging markets and population screening programs. While specific costs can vary, their products for lung cancer and neurocritical care pathways are billable under CMS-issued CPT codes, allowing for a stable revenue model for hospitals.
Qure.ai has established strategic partnerships with leading organizations, including pharmaceutical companies like AstraZeneca, medical device partners such as Medtronic, and technology giants like Microsoft, as well as radiology groups like Strategic Radiology. The company's long-term vision is to make healthcare accessible globally, aiming to impact 1 billion lives by 2030, with a focus on early disease detection and chronic disease screening. Qure.ai has raised $130 million in capital and was recognized as a TIME100 Most Influential Company in 2025, indicating strong stability and growth.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.